HOLX — Hologic Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual income statement for Hologic, fiscal year end - September 28th, USD millions except per share, conversion factor applied.

	2020 September 26th	2021 September 25th	2022 September 24th	2023 September 30th	2024 September 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,776	5,632	4,863	4,030	4,030
Cost of Revenue
Gross Profit	2,253	3,796	3,015	2,251	2,267
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,671	3,174	3,223	3,362	3,148
Operating Profit	1,105	2,459	1,640	668	883
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,002	2,361	1,588	676	865
Provision for Income Taxes
Net Income After Taxes	1,111	1,870	1,302	456	790
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,115	1,872	1,302	456	790
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,115	1,872	1,302	456	790
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.33	7.3	5.28	2.61	3.65